Logiscreen

Pharming Group N.V.

$12.54
Market Cap 879.99M
ROE 4.7%
Gross Margin 90.8%
Debt/Equity 0.4
Current Ratio 2.6
Revenue QoQ -8.4%
EPS QoQ -0.7%
F-Score 6

About

Pharming Group N.V.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
59.93
vs median 33.61
P/B
2.75
vs median 2.16
ROE
0.05
vs median 0.09

Decent quality with acceptable fundamentals

Small-cap company with higher volatility

Similar companies

INMDNEWPLMRISSIIAORTBVS
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics